URSODEOXYCHOLIC ACID LAPL ursodeoxycholic acid 250 mg capsules blister pack

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

ursodeoxycholic acid, Quantity: 250 mg

Available from:

Generic Health Pty Ltd

INN (International Name):

Ursodeoxycholic acid

Pharmaceutical form:

Capsule, hard

Composition:

Excipient Ingredients: maize starch; magnesium stearate; colloidal anhydrous silica; titanium dioxide; sorbitan monolaurate; Gelatin; sodium lauryl sulfate

Administration route:

Oral

Units in package:

100 Capsules, 60 Capsules

Prescription type:

(S4) Prescription Only Medicine

Therapeutic indications:

URSODEOXYCHOLIC ACID LAPL (ursodeoxycholic acid) capsule is indicated in the treatment of chronic cholestatic liver diseases.

Product summary:

Visual Identification: Ursodeoxycholic acid 250 mg capsules: Hard gelatine capsules size 0 with white body and cap.; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius

Authorization status:

Registered

Authorization date:

2016-02-15